ticlopidine has been researched along with Infection in 5 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " with clopidogrel), PPI therapy has been suggested to have--particularly in long term--undesirable effects on gastric epithelium, infection risk, bone strength, and vitamin and mineral levels in serum." | 4.87 | [What has the long clinical experience of PPIs taught us about their putative side effects?]. ( Nissinen, M, 2011) |
| "Thrombotic thrombocytopenic purpura is a thrombotic microangiopathy related to a severe deficiency of ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats, member 13; activity <10%)." | 2.82 | Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy. ( Azoulay, E; Benhamou, Y; Boisseau, P; Coppo, P; de Maistre, E; Delmas, Y; Galicier, L; Mariotte, E; Perez, P; Poullin, P; Provôt, F; Rondeau, E; Stepanian, A; Veyradier, A; Zouiti, F, 2016) |
| " In order to achieve the desired results and, as with all medications, PPIs should always be used appropriately taking care never to exceed correct dosage and duration." | 2.47 | Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections. ( Ferraccioli, GF; Gremese, E; Laria, A; Zoli, A, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 4 (80.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Otoshi, T | 1 |
| Kataoka, Y | 1 |
| Nakagawa, A | 1 |
| Otsuka, K | 1 |
| Tomii, K | 1 |
| Mariotte, E | 1 |
| Azoulay, E | 1 |
| Galicier, L | 1 |
| Rondeau, E | 1 |
| Zouiti, F | 1 |
| Boisseau, P | 1 |
| Poullin, P | 1 |
| de Maistre, E | 1 |
| Provôt, F | 1 |
| Delmas, Y | 1 |
| Perez, P | 1 |
| Benhamou, Y | 1 |
| Stepanian, A | 1 |
| Coppo, P | 1 |
| Veyradier, A | 1 |
| Winning, J | 1 |
| Reichel, J | 1 |
| Eisenhut, Y | 1 |
| Hamacher, J | 1 |
| Kohl, M | 1 |
| Deigner, HP | 1 |
| Claus, RA | 1 |
| Bauer, M | 1 |
| Lösche, W | 1 |
| Laria, A | 1 |
| Zoli, A | 1 |
| Gremese, E | 1 |
| Ferraccioli, GF | 1 |
| Nissinen, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| ADAMTS13-related Prognostic Factors in Adult and Pediatric Thrombotic Thrombocytopenic Purpura[NCT00426686] | 153 participants (Actual) | Observational | 2006-11-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for ticlopidine and Infection
| Article | Year |
|---|---|
Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections.
Topics: Anticoagulants; Aryl Hydrocarbon Hydroxylases; Aspirin; Calcium, Dietary; Clopidogrel; Clostridioide | 2011 |
[What has the long clinical experience of PPIs taught us about their putative side effects?].
Topics: Bone Density; Clopidogrel; Drug Interactions; Gastric Mucosa; Humans; Infections; Minerals; Platelet | 2011 |
1 trial available for ticlopidine and Infection
| Article | Year |
|---|---|
Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross-sectional analysis of the French national registry for thrombotic microangiopathy.
Topics: ADAMTS13 Protein; Adult; Autoantibodies; Autoimmune Diseases; Clopidogrel; Cohort Studies; Cross-Sec | 2016 |
2 other studies available for ticlopidine and Infection
| Article | Year |
|---|---|
Clinical Features and Outcomes of Diffuse Alveolar Hemorrhage During Antithrombotic Therapy: A Retrospective Cohort Study.
Topics: Adult; Aged; Aged, 80 and over; Aspirin; Cilostazol; Clopidogrel; Connective Tissue Diseases; Female | 2016 |
Anti-platelet drugs and outcome in severe infection: clinical impact and underlying mechanisms.
Topics: Adult; Aged; Animals; Cell Line; Clopidogrel; Female; Fibrin; Gene Expression Profiling; Hemodynamic | 2009 |